Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (98)
  • Antibacterial
    (86)
  • Autophagy
    (63)
  • Antibiotic
    (53)
  • DNA/RNA Synthesis
    (25)
  • Endogenous Metabolite
    (25)
  • Parasite
    (25)
  • HIV Protease
    (21)
  • Akt
    (19)
  • Others
    (501)
Filter
Search Result
Results for "

oral

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1297
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    3
    TargetMol | Compound_Libraries
  • Peptide Products
    22
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    6
    TargetMol | Inhibitory_Antibodies
  • Dye Reagents
    2
    TargetMol | Dye_Reagents
  • PROTAC Products
    12
    TargetMol | PROTAC
  • Natural Products
    119
    TargetMol | Natural_Products
  • Recombinant Protein
    23
    TargetMol | Recombinant_Protein
  • Isotope Products
    23
    TargetMol | Isotope_Products
  • Antibody Products
    1
    TargetMol | Antibody_Products
  • Disease Modeling
    8
    TargetMol | Disease_Modeling_Products
  • Cell Research
    9
    TargetMol | Inhibitors_Agonists
Avoralstat
BCX4161
T14358918407-35-9
Avoralstat (BCX4161) is an oral plasma kallikrein (PKK) inhibitor. Which is used for the treatment of hereditary angioedema.
  • $29
In Stock
Size
QTY
Inobrodib
CCS1477, CBP-IN-1
T107172222941-37-7
Inobrodib (CBP-IN-1) is a potent inhibitor of p300/CBP bromodomain.
  • $64
In Stock
Size
QTY
TargetMol | Inhibitor Hot
MK-2206 dihydrochloride
MK-2206 2HCl
T19521032350-13-2
MK-2206 dihydrochloride (MK-2206 2HCl) is a variant Akt inhibitor that inhibits Akt1, Akt2, and Akt3 (IC50=8/12/65 nM) with orally active, highly potent and selective potency. MK-2206 dihydrochloride exhibits antitumor activity.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Quizartinib
AC220
T2066950769-58-1
Quizartinib (AC220) is an inhibitor of FLT3 (Kd: 1.6 nM) and demonstrates high selectivity for FLT3 when tested against a panel of 227 additional kinases.
  • $53
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Finerenone
BAY94-8862, BAY-94-8862, BAY-948862, BAY948862, BAY 94-8862, BAY 948862
T213951050477-31-0
Finerenone (BAY-948862) is a nonsteroidal antagonist of the mineralocorticoid receptor (MR) (IC50=18 nM) with selective and oral activity. Finerenone is used in the treatment of patients with chronic kidney disease with type 2 diabetes.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Imeglimin hydrochloride
EMD 387008 hydrochloride
T7486775351-61-6
Imeglimin hydrochloride (EMD 387008 hydrochloride) is an oral hypoglycemic agent. Imeglimin improves insulin sensitivity, inhibits the production of reactive oxygen species, increases mitochondrial DNA, and improves mitochondrial function.
  • $35
In Stock
Size
QTY
TargetMol | Inhibitor Hot
sbp-7455
T88501884222-74-5
SBP-7455 potently inhibited ULK1/2 enzymatic activity in vitro and in cells, reduced the viability of TNBC cells and had oral bioavailability in mice.
  • $59
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
TC ASK 10
T130991005775-56-3In house
TC ASK 10 is a potent, selective and orally active inhibitor of apoptosis signal-regulating kinase 1 (ASK1)(IC50 of 14 nM).
  • $29
In Stock
Size
QTY
PF-06459988
T164921428774-45-1In house
PF-06459988 is a novel, effective, orally active, irreversible, and selective epidermal growth factor receptor (EGFR) mutant inhibitor. PF-06459988 has high efficiency and high affinity for EGFRs double mutants containing T790M, and has minimal activity against WT EGFR. PF-06459988 makes a candidate drug for the treatment of cancer.
  • $149
5 days
Size
QTY
NOS-IN-1 
2-Imino-4-methylpiperidine (acetate)
T21700165383-72-2In house
NOS-IN-1 (2-Imino-4-methylpiperidine acetate) is a potent and orally active inhibitor of NO synthase (NOS) isoforms. NOS-IN-1 exhibits IC50s of 0.1 μM, 0.2 μM, and 1.1μM for human iNOS (hiNOS), hnNOS and heNOS, respectively.
  • $59
In Stock
Size
QTY
Darglitazone
CP-86325
T22708141200-24-0In house
Darglitazone (CP-86325) is a potent, selective agonist of PPAR-γ with antidiabetic actions. Darglitazone is effective in controlling blood glucose and lipid metabolism.
  • $32
In Stock
Size
QTY
Ursodeoxycholic acid sodium
Ursodiol sodium, Ursodeoxycholic Acid (sodium salt), Ursodeoxycholate sodium, UDCA sodium, UDCA Na, Sodium Ursodeoxycholate
T290782898-95-5In house
Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
  • $29
In Stock
Size
QTY
NHWD-870
T365732115742-03-3In house
NHWD-870 is an effective and selective inhibitor of BET family bromodomain only binding to BRD2, BRD3, BRD4 (IC50 = 2.7 nM), and BRDT. NHWD-870 exhibits potent anti-tumor efficacies and suppresses cancer cell-macrophage interaction through the increase of tumor apoptosis and inhibition of tumor proliferation.
  • $1,630
8-10 weeks
Size
QTY
ARV-471
Vepdegestrant
T397102229711-68-4In house
Vepdegestrant (ARV-471) is an estrogen receptor (ER) α PROTAC molecule that degrades ER in ER-positive breast cancer cell lines with a DC50 of approximately 1 nM. It can reduce the expression of classically regulated ER target genes and inhibit the growth of ER-dependent cell lines (including those expressing ESR1 variants, such as Y537S and D538G) by degrading ER.
  • $186
In Stock
Size
QTY
TargetMol | Citations Cited
PACMA 31
T412771401089-31-3In house
PACMA 31 is an irreversible and covalent inhibitor of protein disulfide isomerase (PDI) with an IC50 of 10 μM. PACMA 31 significantly suppresses ovarian tumor growth and exhibits tumor targeting ability.
  • $32
In Stock
Size
QTY
ABBV-744
ABBV744
T46972138861-99-9In house
ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS.
  • $39
In Stock
Size
QTY
Ensitrelvir
S-217622
T97162647530-73-0In house
Ensitrelvir (S-217622) is an orally active inhibitor of SARS-CoV-2 3CL protease with IC50 of 13 nM.
  • $50
In Stock
Size
QTY
K145 hydrochloride
TQ01381449240-68-9In house
K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 µM and Ki of 6.4 µM. K145 hydrochloride can induce apoptosis and has strong antitumor activity.
  • $50
In Stock
Size
QTY
TargetMol | Citations Cited
Umifenovir hydrochloride
Arbidol hydrochloride, Arbidol HCl
T0104131707-23-8
Umifenovir hydrochloride (Arbidol HCl) , an broad-spectrum antiviral chemical agent, can inhibit cell invade of enveloped viruses by blocking viral fusion with host cell membrane.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
Mirtazapine
Org3770, 6-Azamianserin
T013785650-52-8
Mirtazapine (6-Azamianserin) is a tetracyclic antidepressant with a somewhat unique mechanism of action. Mirtazapine therapy can be associated with transient asymptomatic elevations in serum aminotransferase levels and has been linked to rare instances of clinically apparent acute liver injury.
  • $34
In Stock
Size
QTY
Clemastine fumarate
Meclastine fumarate, Meclastine (fumarate), HS-592 (fumarate)
T014714976-57-9
Clemastine fumarate (Meclastine (fumarate)) is a synthetic ethanolamine with anticholinergic, sedative, and histamine H1 antagonistic properties.
  • $38
In Stock
Size
QTY
Bosutinib
SKI-606
T0152380843-75-4
Bosutinib (SKI-606) is a synthetic quinolone derivative and dual kinase inhibitor that targets both Abl (IC50: 1 nM) and Src (IC50: 1.2 nM) kinases.
  • $33
In Stock
Size
QTY
TargetMol | Citations Cited
Nebivolol hydrochloride
R-65824, R 065824 hydrochloride, Nebivolol HCl
T0154152520-56-4
Nebivolol hydrochloride (R 065824 hydrochloride) is a cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
  • $37
In Stock
Size
QTY
TargetMol | Citations Cited
Secnidazole
RP-14539, PM-185184
T01953366-95-8
Secnidazole (PM-185184) is a second-generation 5-nitroimidazole antimicrobial that is structurally related to other 5-nitroimidazoles including [DB00916] and [DB00911], but displays improved oral absorption and longer terminal elimination half-life than antimicrobial agents in this class [A27210]. Secnidazole is selective against many anaerobic Gram-positive and Gram-negative bacteria and protozoa.
  • $34
In Stock
Size
QTY